Ternium S.A. (TX) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 29, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Mar 31, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the TX SEC filings page.
Ternium S.A. (TX) reported $15.6B in revenue for fiscal year 2025, down 11.6% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025 restored a small accounting profit, but weaker margins and heavy reinvestment kept operations from converting into free cash.
Operating cash flow reached$2.31B in FY2025, yet capital expenditures consumed114.9% of it, leaving free cash flow negative. That cash-conversion mismatch coincided with operating margin falling from12.5% in FY2023 to4.5% in FY2025, making reinvestment more consequential than the return to reported profit.
Debt-to-equity remained low at 0.2x, but long-term debt rose
Revenue fell
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Ternium S.A.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Ternium S.A. has an operating margin of 4.5%, meaning the company retains $5 of operating profit per $100 of revenue. This results in a moderate score of 51/100, indicating healthy but not exceptional operating efficiency. This is down from 7.2% the prior year.
Ternium S.A.'s revenue declined 11.6% year-over-year, from $17.6B to $15.6B. This contraction results in a growth score of 15/100.
Ternium S.A. carries a low D/E ratio of 0.15, meaning only $0.15 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 76/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 2.49, Ternium S.A. holds $2.49 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 70/100.
While Ternium S.A. generated $2.3B in operating cash flow, capex of $2.7B consumed most of it, leaving -$345.5M in free cash flow. This results in a low score of 28/100, reflecting heavy capital investment rather than weak cash generation.
Ternium S.A.'s ROE of 3.6% shows moderate profitability relative to equity, earning a score of 47/100. This is up from -0.4% the prior year.
Ternium S.A. passes 5 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Ternium S.A. generates $5.44 in operating cash flow ($2.3B OCF vs $425.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Ternium S.A. earns $3.29 in operating income for every $1 of interest expense ($705.4M vs $214.4M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
Ternium S.A. generated $15.6B in revenue in fiscal year 2025. This represents a decrease of 11.6% from the prior year.
Ternium S.A.'s EBITDA was $1.5B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 25.6% from the prior year.
Ternium S.A. reported $425.2M in net income in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.
Ternium S.A. earned $0.22 per diluted share (EPS) in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.
Cash & Balance Sheet
Ternium S.A. recorded an outflow of $345.5M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 506.2% from the prior year.
Ternium S.A. held $1.5B in cash against $1.8B in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Ternium S.A.'s gross margin was 15.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.3 percentage points from the prior year.
Ternium S.A.'s operating margin was 4.5% in fiscal year 2025, reflecting core business profitability. This is down 2.6 percentage points from the prior year.
Ternium S.A.'s net profit margin was 2.7% in fiscal year 2025, showing the share of revenue converted to profit. This is up 3.0 percentage points from the prior year.
Ternium S.A.'s ROE was 3.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 4.0 percentage points from the prior year.
Capital Allocation
Ternium S.A. invested $21.8M in research and development in fiscal year 2025. This represents a decrease of 8.4% from the prior year.
Ternium S.A. invested $2.7B in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 46.0% from the prior year.
Not reported for fiscal year 2025.
TX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $15.6B-11.6% | $17.6B+0.2% | $17.6B+7.3% | $16.4B+2.0% | $16.1B+84.2% | $8.7B-14.3% | $10.2B-11.0% | $11.5B+18.1% | $9.7B+34.3% | $7.2B-8.3% | $7.9B |
| Cost of Revenue | $13.3B-10.2% | $14.8B+5.0% | $14.1B+12.5% | $12.5B+26.2% | $9.9B+39.4% | $7.1B-16.0% | $8.5B-0.4% | $8.5B+14.6% | $7.4B+37.5% | $5.4B-16.9% | $6.5B |
| Gross Profit | $2.4B-18.5% | $2.9B-18.8% | $3.6B-9.4% | $3.9B-36.6% | $6.2B+278.8% | $1.6B-6.0% | $1.7B-41.4% | $3.0B+29.3% | $2.3B+24.9% | $1.8B+31.4% | $1.4B |
| R&D Expenses | $21.8M-8.4% | $23.8M+25.3% | $19.0M+16.6% | $16.3M+66.3% | $9.8M+18.1% | $8.3M-17.0% | $10.0M+12.4% | $8.9M-9.2% | $9.8M+6.5% | $9.2M+48.4% | $6.2M |
| Operating Income | $705.4M-44.2% | $1.3B-42.5% | $2.2B-18.6% | $2.7B-48.8% | $5.3B+388.3% | $1.1B+24.9% | $864.6M-59.0% | $2.1B+44.7% | $1.5B+27.6% | $1.1B+78.6% | $639.3M |
| EBITDA | $1.5B-25.6% | $2.0B-29.7% | $2.9B-13.9% | $3.3B-43.4% | $5.9B+242.8% | $1.7B+12.1% | $1.5B-43.4% | $2.7B+39.7% | $1.9B+24.7% | $1.5B+44.3% | $1.1B |
| Interest Expense | $214.4M+9.3% | $196.2M+56.5% | $125.4M+168.3% | $46.7M+73.1% | $27.0M-42.1% | $46.6M-47.2% | $88.3M-32.7% | $131.2M+14.5% | $114.6M+27.4% | $90.0M+0.5% | $89.5M |
| Income Tax | $345.1M-37.7% | $554.2M+65.7% | $334.4M-41.7% | $573.7M-58.9% | $1.4B+379.3% | $291.5M+48.3% | $196.5M-46.8% | $369.4M+9.7% | $336.9M-18.1% | $411.5M+98.5% | $207.3M |
| Net Income | $425.2Mn/m | -$53.7M-107.9% | $676.0M-61.8% | $1.8B-53.8% | $3.8B+391.4% | $778.5M+38.0% | $564.3M-62.5% | $1.5B+70.0% | $886.2M+48.8% | $595.6M+7229.2% | $8.1M |
| EPS (Basic) | $0.22n/m | -$0.03-108.8% | $0.34-62.2% | $0.90-53.8% | $1.95+387.5% | $0.40+37.9% | $0.29 | N/A | N/A | N/A | N/A |
| EPS (Diluted) | $0.22n/m | -$0.03-108.8% | $0.34-62.2% | $0.90-53.8% | $1.95+387.5% | $0.40+37.9% | $0.29 | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: SG&A Expenses, Diluted Shares (Avg).
TX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $23.6B+2.1% | $23.1B-4.3% | $24.2B+38.2% | $17.5B+2.3% | $17.1B+33.0% | $12.9B-0.6% | $12.9B+3.1% | $12.5B+3.5% | $12.1B+45.7% | $8.3B | N/A |
| Current Assets | $9.8B-11.6% | $11.1B-7.9% | $12.0B+36.0% | $8.8B+2.8% | $8.6B+88.5% | $4.6B+9.3% | $4.2B-5.6% | $4.4B+0.7% | $4.4B+62.8% | $2.7B | N/A |
| Cash & Equivalents | $1.5B-9.5% | $1.7B-8.4% | $1.8B+11.7% | $1.7B+29.5% | $1.3B+137.3% | $537.9M+3.4% | $520.0M+107.5% | $250.5M-25.8% | $337.8M+84.1% | $183.5M+21.1% | $151.5M |
| Inventory | $4.1B-13.8% | $4.8B-4.0% | $4.9B+42.6% | $3.5B-11.2% | $3.9B+95.2% | $2.0B-7.3% | $2.2B-19.8% | $2.7B+5.4% | $2.6B+54.8% | $1.6B+4.4% | $1.6B |
| Goodwill | $1.0B-1.9% | $1.0B+2.6% | $996.0M+5.5% | $944.4M+4.7% | $902.3M-0.7% | $908.6M-3.7% | $943.8M-6.8% | $1.0B-7.3% | $1.1B+29.7% | $842.6M-5.1% | $888.2M |
| Total Liabilities | $7.5B+6.7% | $7.0B-5.0% | $7.4B+97.9% | $3.7B-23.4% | $4.9B+10.2% | $4.4B-15.5% | $5.2B+3.1% | $5.1B-19.2% | $6.3B+98.6% | $3.2B | N/A |
| Current Liabilities | $3.9B+2.5% | $3.8B+1.0% | $3.8B+71.4% | $2.2B-31.0% | $3.2B+73.4% | $1.9B+4.8% | $1.8B-3.2% | $1.8B-35.4% | $2.8B+54.4% | $1.8B | N/A |
| Non-Current Liabilities | $3.5B+11.9% | $3.2B-11.5% | $3.6B+136.8% | $1.5B-8.7% | $1.6B-35.6% | $2.6B-25.9% | $3.5B+6.7% | $3.2B-6.0% | $3.4B+159.9% | $1.3B | N/A |
| Long-Term Debt | $1.8B+16.3% | $1.6B+29.4% | $1.2B+126.4% | $532.7M-18.9% | $656.5M-50.5% | $1.3B-18.5% | $1.6B-0.5% | $1.6B-4.6% | $1.7B+332.6% | $396.7M | N/A |
| Total Equity | $11.9B-0.2% | $12.0B-3.6% | $12.4B+4.8% | $11.8B+12.4% | $10.5B+44.6% | $7.3B+10.2% | $6.6B+3.4% | $6.4B+27.6% | $5.0B+14.1% | $4.4B-8.6% | $4.8B |
Not reported in any period shown, so not listed: Short-Term Investments, Accounts Receivable, Long-Term Investments, Retained Earnings.
TX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.3B+21.4% | $1.9B-23.8% | $2.5B-9.1% | $2.8B+2.8% | $2.7B+52.0% | $1.8B+6.9% | $1.6B-5.3% | $1.7B+353.1% | $383.9M-65.1% | $1.1B-16.9% | $1.3B |
| Depreciation & Amortization | $788.3M+6.1% | $743.3M+13.0% | $657.7M+6.7% | $616.5M+4.2% | $591.8M-6.2% | $631.1M-4.5% | $661.1M+12.2% | $589.3M+24.2% | $474.3M+16.6% | $406.9M-6.2% | $433.8M |
| Capital Expenditures | $2.7B+46.0% | $1.8B+51.6% | $1.2B+107.0% | $580.6M+10.9% | $523.6M-6.5% | $560.0M-46.8% | $1.1B+102.3% | $520.3M+27.1% | $409.4M-6.0% | $435.5M-6.7% | $466.6M |
| Free Cash Flow | -$345.5M-506.2% | $85.0M-93.5% | $1.3B-40.2% | $2.2B+0.9% | $2.2B+79.3% | $1.2B+101.8% | $595.4M-51.2% | $1.2Bn/m | -$25.5M-103.8% | $664.1M-22.5% | $856.8M |
| Investing Cash Flow | -$2.0Bn/m | -$1.4Bn/m | -$1.5Bn/m | -$1.3Bn/m | -$1.0Bn/m | -$1.2Bn/m | -$1.2Bn/m | -$457.0Mn/m | -$2.0Bn/m | -$554.7Mn/m | -$572.1M |
| Financing Cash Flow | -$500.6Mn/m | -$488.4Mn/m | -$766.4Mn/m | -$1.0Bn/m | -$854.4Mn/m | -$506.3Mn/m | -$150.5Mn/m | -$1.3B-173.4% | $1.8Bn/m | -$508.7Mn/m | -$809.6M |
| Dividends Paid | $530.0M-12.9% | $608.6M+6.9% | $569.3M+7.4% | $530.0M-6.9% | $569.3Mn/m | $0-100.0% | $235.6M+9.1% | $215.9M+10.0% | $196.3M+11.1% | $176.7M0.0% | $176.7M |
Not reported in any period shown, so not listed: Stock-Based Compensation, Share Buybacks.
TX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 15.1%-1.3pp | 16.4%-3.8pp | 20.2%-3.7pp | 23.9%-14.6pp | 38.5%+19.8pp | 18.7%+1.7pp | 17.1%-8.9pp | 25.9%+2.3pp | 23.7%-1.8pp | 25.5%+7.7pp | 17.8% |
| Operating Margin | 4.5%-2.6pp | 7.2%-5.3pp | 12.5%-4.0pp | 16.4%-16.3pp | 32.8%+20.4pp | 12.4%+3.9pp | 8.5%-9.9pp | 18.4%+3.4pp | 15.0%-0.8pp | 15.8%+7.7pp | 8.1% |
| Net Margin | 2.7%+3.0pp | -0.3%-4.1pp | 3.8%-6.9pp | 10.8%-13.0pp | 23.8%+14.9pp | 8.9%+3.4pp | 5.5%-7.6pp | 13.2%+4.0pp | 9.1%+0.9pp | 8.3%+8.2pp | 0.1% |
| Return on Equity | 3.6%+4.0pp | -0.4%-5.9pp | 5.4%-9.5pp | 14.9%-21.4pp | 36.3%+25.6pp | 10.7%+2.2pp | 8.5%-15.0pp | 23.6%+5.9pp | 17.7%+4.1pp | 13.6%+13.4pp | 0.2% |
| Return on Assets | 1.8%+2.0pp | -0.2%-3.0pp | 2.8%-7.3pp | 10.1%-12.3pp | 22.4%+16.3pp | 6.1%+1.7pp | 4.4%-7.6pp | 12.0%+4.7pp | 7.3%+0.2pp | 7.2% | N/A |
| Current Ratio | 2.49-0.4x | 2.89-0.3x | 3.17-0.8x | 3.99+1.3x | 2.68+0.2x | 2.46+0.1x | 2.36-0.1x | 2.42+0.9x | 1.55+0.1x | 1.47 | N/A |
| Debt-to-Equity | 0.150.0x | 0.130.0x | 0.10+0.1x | 0.040.0x | 0.06-0.1x | 0.18-0.1x | 0.250.0x | 0.26-0.1x | 0.34+0.3x | 0.09 | N/A |
| Liabilities-to-Equity | 0.630.0x | 0.580.0x | 0.59+0.3x | 0.31-0.1x | 0.46-0.1x | 0.61-0.2x | 0.790.0x | 0.79-0.5x | 1.25+0.5x | 0.72 | N/A |
| Asset Turnover | 0.66-0.1x | 0.760.0x | 0.73-0.2x | 0.940.0x | 0.94+0.3x | 0.68-0.1x | 0.79-0.1x | 0.91+0.1x | 0.80-0.1x | 0.87 | N/A |
| FCF Margin | -2.2%-2.7pp | 0.5%-6.9pp | 7.4%-5.8pp | 13.2%-0.2pp | 13.4%-0.4pp | 13.8%+7.9pp | 5.8%-4.8pp | 10.6%+10.9pp | -0.3%-9.4pp | 9.2%-1.7pp | 10.9% |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Ternium S.A. TX | FY2025 | $15.6B | $425.2M | 2.7% | $10.6B | 48/100 |
| Gerdau S.A. GGB | FY2025 | $12.8B | $253.2M | 2.0% | $8.8B | 53/100 |
| Commercial Metals Company CMC | FY2026 | $9.4B | $655.8M | 7.0% | $7.1B | 56/100 |
| Cleveland-Cliffs Inc. CLF | FY2025 | $18.6B | -$1.5B | -7.9% | $8.0B | 29/100 |
| Groupo Simec, S.A.B de C.V. SIM | FY2024 | $1.6B | $502.9M | 31.2% | $4.0B | 65/100 |
| Reliance, Inc. RS | FY2025 | $14.3B | $739.4M | 5.2% | $22.3B | 58/100 |
Where Ternium S.A. Ranks
Frequently Asked Questions
What is Ternium S.A.'s annual revenue?
Ternium S.A. (TX) reported $15.6B in total revenue for fiscal year 2025. This represents a -11.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Ternium S.A.'s revenue growing?
Ternium S.A. (TX) revenue declined by 11.6% year-over-year, from $17.6B to $15.6B in fiscal year 2025.
Is Ternium S.A. profitable?
Yes, Ternium S.A. (TX) reported a net income of $425.2M in fiscal year 2025, with a net profit margin of 2.7%.
What is Ternium S.A.'s EBITDA?
Ternium S.A. (TX) had EBITDA of $1.5B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Ternium S.A. have?
As of fiscal year 2025, Ternium S.A. (TX) had $1.5B in cash and equivalents against $1.8B in long-term debt.
What is Ternium S.A.'s gross margin?
Ternium S.A. (TX) had a gross margin of 15.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Ternium S.A.'s operating margin?
Ternium S.A. (TX) had an operating margin of 4.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Ternium S.A.'s net profit margin?
Ternium S.A. (TX) had a net profit margin of 2.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Ternium S.A.'s return on equity (ROE)?
Ternium S.A. (TX) has a return on equity of 3.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Ternium S.A.'s free cash flow?
Ternium S.A. (TX) recorded an outflow of $345.5M in free cash flow during fiscal year 2025. This represents a -506.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Ternium S.A.'s operating cash flow?
Ternium S.A. (TX) generated $2.3B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Ternium S.A.'s total assets?
Ternium S.A. (TX) had $23.6B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Ternium S.A.'s capital expenditures?
Ternium S.A. (TX) invested $2.7B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Ternium S.A. spend on research and development?
Ternium S.A. (TX) invested $21.8M in research and development during fiscal year 2025.
What is Ternium S.A.'s current ratio?
Ternium S.A. (TX) had a current ratio of 2.49 as of fiscal year 2025, which is generally considered healthy.
What is Ternium S.A.'s debt-to-equity ratio?
Ternium S.A. (TX) had a debt-to-equity ratio of 0.15 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is Ternium S.A.'s liabilities-to-equity ratio?
Ternium S.A. (TX) had a liabilities-to-equity ratio of 0.63 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is Ternium S.A.'s return on assets (ROA)?
Ternium S.A. (TX) had a return on assets of 1.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Ternium S.A.'s P/E ratio?
Ternium S.A. (TX) trades at 25.0x earnings, its market capitalization divided by $425.2M net income, FY2025. The market capitalization is $10.6B as of Oct 29, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Ternium S.A.'s price-to-sales ratio?
Ternium S.A. (TX) trades at 0.7x sales, its market capitalization divided by $15.6B revenue, FY2025. The market capitalization is $10.6B as of Oct 29, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Ternium S.A.'s Piotroski F-Score?
Ternium S.A. (TX) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Ternium S.A.'s earnings high quality?
Ternium S.A. (TX) has an earnings quality ratio of 5.44x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Ternium S.A. cover its interest payments?
Ternium S.A. (TX) has an interest coverage ratio of 3.29x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Ternium S.A.?
Ternium S.A. (TX) scores 48 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.